TB-500 peptide for sale: vial quality, COAs, and sourcing

The market for TB-500 vials is crowded, and most of it is loud. Vendors post ≥99% purity claims on landing pages without a chromatogram in sight, price points swing wildly between similar-looking products, and documentation standards range from legitimately rigorous to essentially decorative. Researchers who skip supplier evaluation end up running protocols on compounds that independent testing has confirmed can range from 85.82% to 99.9% purity, a gap that makes results unreliable at best and meaningless at worst.

When looking for TB-500 peptide for sale, working through a defined checklist makes the process far more manageable: the right vial format for your protocol, a COA you can actually verify, honest pricing expectations, and a clear understanding of the regulatory framework you’re operating within. For researchers prioritizing verified documentation, wholesale-focused suppliers like R-Peptide Supply (Grey Peptide Shop) offer bundled multi-vial formats alongside rigorous documentation standards rather than racing to the lowest single-vial price. This guide gives you every question to ask before you place an order.

What Thymosin Beta-4 is studied for in research settings

TB-500 is the commercial designation for a fragment of Thymosin Beta-4, a naturally occurring peptide that plays a role in actin sequestration and cytoskeletal regulation. In pre-clinical and in-vitro settings, it has been investigated across a range of tissue repair and regeneration contexts: wound closure models involving keratinocyte and fibroblast migration, angiogenesis and vascular repair studies, cardiac ischemia recovery protocols, corneal healing research, and anti-inflammatory pathway modulation. The cellular migration work is particularly well-documented, with multiple studies examining how TB-500 influences cell motility through its effect on actin dynamics. You can also review registered trial listings that contextualize some clinical and preclinical activities around related peptides.

This breadth of research application explains why demand for TB-500 stays consistently high across labs, resellers, and independent researchers. It also directly shapes purchasing decisions. A researcher running a short single-endpoint cellular assay has different quantity needs than someone conducting a multi-week comparative tissue repair protocol. Understanding your application before you order determines which vial format makes sense and whether a multi-vial bundle is the more rational buy.

TB-500 peptide for sale: 5mg vs 10mg vials and format selection

Lyophilized vials are the standard format for lab-grade TB-500. The two dominant sizes are 5mg and 10mg, and the cost-per-mg math is worth doing before you order. Current market pricing from established research vendors places 5mg vials at roughly $70, $78, while 10mg vials run $112, $165 depending on the supplier and the quality of their documentation. At the low end of 10mg pricing, you’re paying about $11.20 per mg. At the high end of 5mg pricing, that number rises to $15.60 per mg. Volume discount tiers, typically 5% off at five or more units and 10% off at nine or more, improve these numbers further for bulk buyers. If you need a standardized multi-vial option, consider a verified TB-500 multi-vial listing to compare formats.

The 5mg format suits single-run experiments where flexibility matters more than economy. Researchers working sustained protocols, resellers building inventory, and labs running multi-condition studies find the 10mg format or multi-vial bundles significantly more cost-efficient. Capsule formats (such as 500mcg per capsule at 60 capsules per bottle) exist but are not standard for controlled lab environments. Dose precision is harder to maintain and reconstitution variables are removed from the researcher’s hands, which matters when you need traceable, reproducible data.

Storage from shipping to reconstitution

Lyophilized TB-500 is stable in transit for several weeks when cold-packed, but long-term storage requires refrigeration at 4°C or freezing at -20°C. Once you reconstitute the lyophilized powder using bacteriostatic water, the solution should be stored at 2, 8°C, protected from light, and used within approximately 28, 30 days. Add the reconstitution date, solvent used, and final concentration to each vial label. Avoid shaking during reconstitution: inject the diluent slowly down the inner wall of the vial, then swirl gently. Repeated freeze-thaw cycles and light exposure both degrade peptide integrity. For a laboratory-focused step-by-step protocol that demonstrates best practices for reconstitution and handling, see a dedicated TB-500 reconstitution guide.

How to read and verify a TB-500 COA before you buy

A PDF labeled “COA” is not the same as verified third-party documentation. The distinction matters because Finnrick Analytics, which has independently tested 97 TB-500 samples from 13 vendors, found real-world purity ranging from 85.82% to 99.9%, and some samples contained no TB-500 at all. Vendor claims and independent results do not always align, which is exactly why documentation structure tells you more than any marketing copy will. Independent third-party testing summaries and vendor discussions of lab verification help illustrate how common documentation gaps are across suppliers.

A credible COA for a research-grade TB-500 vial should include the issuing lab’s name and address (ideally from an ISO 17025-accredited facility), the specific lot or batch number that matches your order, HPLC purity data with a supporting chromatogram, and mass spectrometry confirmation of molecular identity. The observed molecular weight should match the theoretical. A purity percentage with no chromatogram attached is not a COA; it’s a claim formatted like one.

Red flags that should disqualify a supplier from consideration:

• No lot number on the COA, or a lot number that doesn’t match your product label
• Purity percentage with no HPLC chromatogram or raw data
• Identity testing absent from the report entirely
• The “third-party” lab turns out to be affiliated with or operated by the vendor
• COAs that appear nearly identical across multiple batches or product lines
• Analysis dates more than 12 months old relative to the current batch

When in doubt, cross-reference the lot number with the vendor’s documentation page and look for the raw lab report rather than a reformatted version, an example of a batch lab report published independently can help you recognize what raw data looks like. Suppliers who make COA verification easy are telling you something important about how they operate.

Pricing benchmarks and what drives the cost gap

Current market pricing places 5mg vials at $70, $78 and 10mg vials between $112 and $165. The spread within those 10mg figures isn’t arbitrary. Higher-priced options typically reflect multi-lab verification, more detailed documentation, and domestic manufacturing. Lower-priced 10mg listings frequently skip independent identity testing or post generic COAs that don’t hold up to the verification checklist above.

An $8, $10 per-vial premium for verified third-party documentation is modest compared to the cost of running a protocol on a compound that tests below 90% purity and produces results you can’t trust or replicate. Calculate cost-per-verified-mg rather than cost-per-vial when comparing suppliers side by side. Wholesale and multi-vial formats narrow the per-unit cost significantly for researchers ordering at volume, making documentation-first sourcing financially accessible rather than a premium-only option.

Why researchers commonly stack TB-500: the GLOW bundle

TB-500 appears frequently in multi-peptide research protocols because its studied mechanisms complement compounds that target different biological pathways. BPC-157 is investigated for its effects on gut lining integrity and connective tissue signaling. GHK-Cu, the copper peptide, is explored for its role in skin remodeling and anti-inflammatory activity. In recovery and regenerative research contexts, these compounds are often examined together precisely because their proposed mechanisms of action operate along different but complementary routes.

Sourcing multiple compounds from different vendors creates documentation fragmentation: mismatched lot numbers, inconsistent testing labs, different storage handling timelines, and separate ordering workflows for each. R-Peptide Supply’s GLOW stack (BPC-157 + GHK-Cu + TB-500) addresses this as a purpose-built research bundle. Each compound ships with its own COA, lot documentation is matched across the order, and bundle pricing improves per-unit economics compared to buying the same compounds individually. Researchers who want TB-500 as a standalone vial can order the single-vial TB-500 listing too; the GLOW stack option exists for those running multi-compound protocols who want the sourcing friction removed. You can also consult documented customer reviews to see how laboratories have evaluated bundle vs. single-item purchasing in practice.

Regulatory and RUO compliance: what to confirm before ordering

TB-500 is not FDA-approved for any human therapeutic indication in the United States. As of 2026, it remains outside the FDA’s approved drug framework and has been subject to restrictions under the agency’s bulk-substance enforcement approach for compounding. It carries no EU-wide marketing authorization as a licensed medicine and is not a licensed product in the UK. All three jurisdictions treat it as outside routine commercial human-use channels. TB-500 is also prohibited under WADA anti-doping rules.

In the US, it is sold legally as a research-use-only (RUO) compound, which means vendors must not market it for human consumption, diagnosis, or treatment. This framing is not a technicality; it’s the compliance boundary that defines how legitimate suppliers position and label their products. When evaluating any vendor, check that RUO language appears consistently across product listings, documentation, and order communications. A supplier making implicit or explicit therapeutic claims on their product pages has already signaled they are not operating within the compliance framework that protects both your purchase and your research workflow.

Sourcing from an RUO-compliant supplier is not just a quality decision; it’s a structural one. Verified COAs for every compound and consistent RUO framing across all listings represent the standard that serious buyers should hold all vendors to, including R-Peptide Supply, which maintains both.

TB-500 peptide for sale: sourcing checklist before you order

Before purchasing research peptide TB-500 from any supplier, work through these four confirmations:

• Format and concentration: Verify the vial size matches your actual protocol needs, 5mg for single experiments, 10mg or multi-vial bundles for sustained work.
• COA quality: Confirm the certificate includes lot-specific HPLC chromatogram and mass spectrometry identity data from an independent, ideally ISO 17025-accredited lab.
• Pricing benchmarks: Cross-check the listed price against the $70, $78 range for 5mg and $112, $165 for 10mg; significant deviation in either direction warrants closer scrutiny.
• RUO compliance: Check that the vendor’s listings use consistent research-use-only language with no therapeutic claims anywhere on the site.

Researchers planning multi-compound protocols should consider the GLOW stack from R-Peptide Supply as a streamlined path to sourcing BPC-157, GHK-Cu, and TB-500 in a single order with matched documentation for each compound. For labs managing order minimums and turnaround times as part of their sourcing criteria, wholesale-focused suppliers that also offer volume shipping thresholds and responsive support are worth factoring into that evaluation.

The sourcing decision is made before any data is generated. When you buy TB-500 peptide for sale from a verified, documentation-first supplier, you protect every downstream result, getting that decision right is foundational to research integrity.

Frequently asked questions

Is TB-500 for research use only?

Yes. In the United States, TB-500 is sold exclusively as a research-use-only (RUO) compound. It is not FDA-approved for human therapeutic use, and legitimate vendors must not market it for human consumption, diagnosis, or treatment. The same RUO status applies in the EU and UK, where it holds no marketing authorization as a licensed medicine.

How do I verify a TB-500 COA?

Start by confirming the lot number on the COA matches the number on your product label. Then check that the report includes HPLC purity data with an actual chromatogram, not just a percentage, and mass spectrometry confirmation of molecular identity. Finally, verify the issuing lab is genuinely independent and ideally ISO 17025-accredited. If the vendor’s COA page links to raw lab reports rather than reformatted summaries, that’s a positive signal, compare with third-party testing write-ups for examples of acceptable reporting.

What purity should I expect when buying TB-500 peptide for sale?

Independent third-party testing across multiple vendors has found real-world TB-500 purity ranging from 85.82% to 99.9%. Vendors claiming ≥99% purity without a supporting chromatogram should be treated with skepticism. For reliable research data, target suppliers who document verified purity above 98% with lot-specific HPLC evidence.

Further reading and resources:

• Registered clinical trial listing for context on related peptide research.
• Third-party testing overview that discusses independent verification for BPC-157 and TB-500.
• Example batch lab report showing raw analytical results for a TB-500 batch.
• TB-500 reconstitution guide demonstrating laboratory preparation protocols.